Analyst Reco. Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Market Closed - Nyse Other stock markets 04:00:02 2024-05-20 pm EDT			5-day change	1st Jan Change
98.46 ^USD	-0.63%		+0.43%	-2.32%

May. 17	JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	MT
May. 15	Argus Adjusts Price Target on Cardinal Health to $115 From $120	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	May. 17	MT
Argus Adjusts Price Target on Cardinal Health to $115 From $120	May. 15	MT
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116	May. 07	MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110	May. 06	MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94	May. 03	MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134	May. 03	MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118	May. 02	MT
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96	Apr. 29	MT
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating	Apr. 24	MT
Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating	Apr. 23	MT
Leerink Partners Adjusts Price Target on Cardinal Health to $118 From $125	Apr. 22	MT
Cardinal Health says contracts with UnitedHealth's OptumRx will not be renewed	Apr. 22	RE
Cardinal Health will not renew contracts with OptumRx	Apr. 22	RE
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target	Feb. 26	MT
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120	Feb. 09	MT
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating	Feb. 05	MT
UBS Raises Cardinal Health Price Target to $122 From $114, Maintains Buy Rating	Jan. 29	MT
Wells Fargo Starts Coverage on Cardinal Health with Underweight Rating, $96 Price Target	Dec. 14	MT
JPMorgan Raises Cardinal Health's Price Target to $112 From $101, Maintains Neutral Rating	Nov. 17	MT
Investors see life through rose-colored glasses	Nov. 17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Analyst Reco.

Filters